Last update:
Oncology news
Microneedles may help light reach hard-to-treat skin cancers
Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells. The treatment has become an important option for certain skin cancers because it can target diseased tissue ...
7 hours ago
0
3
Druggable target that makes metastatic cancer cells easier to kill identified
Researchers at the University of Illinois Chicago have identified a molecular switch that helps determine whether cancer cells remain soft and difficult to destroy or become stiff enough for the immune system to attack.
6 hours ago
0
0
Viagra may reduce cancer metastasis, study shows
Viagra was originally developed to treat high blood pressure and chest pain caused by reduced blood flow to the heart, but over the past three decades it has become the world's best-known therapy for erectile dysfunction. ...
12 hours ago
0
9
Thymus-derived hormone may suppress age-related inflammation and boost cancer therapy
Chronic, low-grade inflammation in the body—a phenomenon known as "inflammaging" because it increases with age—has been linked to many of today's leading causes of illness and death, including cancer, heart disease, metabolic ...
18 hours ago
0
21
Researchers find new strategy to help immune system fight pancreatic cancer
Researchers from the University of Minnesota Medical School have identified why pancreatic cancer is difficult for the immune system to recognize and attack, paving the way for a new approach to improve immunotherapy. The ...
7 hours ago
0
0
Paradigm shift in oncology: The emergence of point-of-care diagnostic technology
Who doesn't want cancer testing results at lower cost, with greater speed and accuracy? Interdisciplinary innovators like Cancer Center at Illinois (CCIL) program leader Brian Cunningham are among the pioneers of the emerging ...
9 hours ago
0
1
New protein structure reveals cancer signaling mechanism and potential drug target
Malignant melanoma is one of the most dangerous forms of cancer. Around half of melanomas and about 7% of all other cancers carry a mutation in a protein called BRAF. This mutation disrupts the regulation of cell division, ...
5 hours ago
0
0
Heart risk tools predict certain cancers about as well as they predict heart disease
Risk calculators that doctors use to estimate a person's risk of a heart attack or stroke work about as well for predicting certain cancers, according to a new study by UCL (University College London) researchers. The tools, ...
7 hours ago
0
1
Biological sex linked to protein changes in lung adenocarcinoma and other cancers
Biological sex factors into cancer in ways you might not expect. In lung cancer, a form called squamous cell carcinoma disproportionately affects male patients, while adenocarcinoma occurs more frequently in female patients. ...
6 hours ago
0
0
Smoldering myeloma: Lauren Laverne's diagnosis explained
When the BBC presenter Lauren Laverne revealed she has smoldering myeloma, the diagnosis sounded more alarming than it is. Her situation is more subtle and nuanced than the word "myeloma" suggests.
11 hours ago
0
1
Blood cancer marker could help identify patients at high risk
Australian researchers have found a new biomarker for multiple myeloma that could help doctors rapidly identify patients at greatest risk of poor outcomes, enabling more personalized and effective treatments. Multiple myeloma ...
12 hours ago
0
2
New AI-guided technique may improve delivery of brain tumor therapy
Researchers presented an artificial intelligence (AI)-guided technique at the Society of NeuroInterventional Surgery's (SNIS) 23rd Annual Meeting that may improve the accuracy of delivering experimental therapies directly ...
14 hours ago
0
2
Researchers uncover 'hidden key' to immunotherapy for intractable brain tumors
Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune "brakes" exploited by tumors to evade attack—show limited efficacy in some brain tumors. A KAIST research team ...
Jul 20, 2026
0
13
Decentralized clinical trials expand access for rural and underserved patients
A Mayo Clinic study published in JAMA Network Open found that bringing some or all clinical trial-related activities directly to patients can help overcome barriers that prevent many people from participating. Increased participation ...
Jul 20, 2026
0
2
Mapping human bone marrow yields new tool, insights on blood cancer
Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms. The method, published June 30 in Leukemia, compares the physical locations ...
Jul 20, 2026
0
5
Tumor organoid tech advances precision medicine cancer treatments
Significant advances have been made in the development of patient-derived tumor "organoids" for preclinical research in two new studies led by Weill Cornell Medicine investigators. Organoids are three-dimensional clumps of ...
Jul 20, 2026
0
2
Many cancer survivors have impairments that make using mobile devices and websites difficult
Megan (not her real name) had always taken pride in her ability to meet someone once and remember their name. Then came a breast cancer diagnosis in her 40s, chemotherapy and the brain fog that followed. She struggled to ...
Jul 20, 2026
0
4
Clinical trial: Oral drug keeps cancer treatment on track for patients who develop persistently low platelet counts
In a phase 2 clinical trial, Mass General Brigham Cancer Institute researchers found that the oral drug avatrombopag was safe and effective in managing persistent chemotherapy-induced thrombocytopenia (CIT) in more than half ...
Jul 20, 2026
0
2
DNA blood test improves patient selection for radiopharmaceutical therapy in prostate cancer
A noninvasive DNA blood test can identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are most likely to benefit from 223Ra radiopharmaceutical therapy and monitor their progress throughout treatment, ...
Jul 20, 2026
0
3
Blood vessels guide immune cells to metastases
It has long been suspected that endothelial cells, the specialized cells lining the inner walls of blood vessels, play a key role in determining how the body's immune system responds to tumors. Researchers at the German Cancer ...
Jul 20, 2026
0
2
Have the clinical signs of a serious type of blood cancer changed?
Researchers have found that, with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should use different criteria to identify patients with poor chances of survival. The study was published online ...
Jul 20, 2026
0
4
New topology-based biomarkers may improve breast cancer prediction
For decades, pathologists have diagnosed and graded breast cancer by looking at tissue samples under a microscope, searching for telltale signs of disorder in the structure of cells and tissues. Now, researchers at Columbia ...
Jul 19, 2026
0
17
Scientists develop DNA-delivered immunotherapy that targets ovarian cancer more effectively
Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against ovarian cancer in preclinical studies. It's a major development for this type of immunotherapy, which has been used ...
Jul 19, 2026
0
9
AI detection not automatically better for colorectal cancer screening in Lynch syndrome, study shows
People with Lynch syndrome, the most common hereditary predisposition to colorectal cancer, face a markedly increased cancer risk and therefore undergo regular colonoscopies. Researchers from the University Hospital Bonn ...
Jul 19, 2026
0
10
Cutting-edge drug shows promise for patients with NRAS-driven melanoma
A research team from Huntsman Cancer Institute at the University of Utah (the U) reports that a pathway-targeted therapy could be an effective treatment for certain melanoma patients and fill an unmet clinical need for patients ...
Jul 18, 2026
0
23
